In November, Omeros announced the results from the clinical trial showed the drug met co-primary efficacy endpoints with better pupil dilation and pain reduction after surgery.
More Articles on Ophthalmology:
56 Physician-Owned Hospitals to Know
20 Physicians Scattered Throughout 113th Congress
Ophthalmologist on the Move: Dr. Augustus Stern Joins MD’s Bergman Eye Center
Next Up in Ophthalmology
-
The highest-paid ophthalmologist in New York City, the most populated city in the Northeast, earns $627,800 per year, according to…
-
HHS’ Office of the Inspector General issued a favorable result regarding a proposal to offer discounts to certain ASCs in…
-
The Tennessee General Assembly is considering companion bills that would allow optometrists to perform additional procedures. House Bill 1952 and…
Join the 40,000+ ASC leaders who start their day with Becker's
